VeonGen Therapeutics GmbH
2 clinical trials · Sponsor
◉ Watch VeonGen Therapeutics GmbH
| Record | Firm | Date |
|---|---|---|
| Safety and Preliminary Efficacy of VG801 in Patients With ABCA4 Mutation-associated Retinal Dystrophy (Stargardt Disease) (NCT07002398) | VeonGen Therapeutics GmbH | 2024-12-23 |
| Safety and Tolerability of Intravitreal Administration of VG901 in Patients With Retinitis Pigmentosa Due to Mutations in the CNGA1 Gene (NCT06291935) | VeonGen Therapeutics GmbH | 2023-09-01 |
Track VeonGen Therapeutics GmbH automatically
Every clearance here is in the API, with alerts when new ones post.